INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE EVIDENCE INDEX

The Study Library.

8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.

An expert overview of the literature, useful as background reading.

159 studies · page 3 of 7

2015 / Narrative review

Decreased quantity and quality of sleep are linked to cardiovascular disease risk factors like hypertension, obesity, diabetes, and dyslipidemia.

This review examines literature regarding the adverse effects of primary sleep deficiency and deprivation on the cardiovascular system. Decreased sleep quantity and quality have been associated with cardiovascular disease risk factors, including hypertension, obesity, diabetes, and dyslipidemia. The authors cite endothelial dysfunction as a common underlying mechanism connecting sleep deficiency to cardiovascular disease.

Shows an association, not proof of cause and effect.

Kohansieh M, Makaryus AN Int J Hypertens, 2015. PMID 26495139

2014 / Narrative review

A review explores dietary salt reduction at a population level as a strategy to combat Nigeria's rising hypertension burden.

This review examines population-wide dietary salt reduction to reduce the burden of hypertension in Nigeria. Hypertension prevalence in Nigeria has increased from 11% two decades ago to approximately 30% in recent times. The authors explore evidence for salt reduction strategies, review methods used in other countries, and provide recommendations for implementation in the Nigerian context.

Mezue K Perspect Public Health, 2014. PMID 24002906

2014 / Narrative review

Being born very preterm or very small is linked to cardiometabolic risk factors such as higher blood pressure, lower lean mass, and impaired glucose regulation.

This review examines cardiometabolic risk factors in adults born very preterm or very small. Data suggest an increased risk of type 2 diabetes and accumulating evidence of risk factors including higher blood pressure, lower lean body mass, impaired glucose regulation, and potentially a more atherogenic lipid profile. Adults born very small or very preterm also undertake less non-conditioning physical activity and may consume less fruit and milk products.

Shows an association, not proof of cause and effect.

Kajantie E, Hovi P Semin Fetal Neonatal Med, 2014. PMID 24332842

2014 / Narrative review

A review examined evidence linking refined dietary sugar intake to retinal and eye diseases, including diabetic and hypertensive retinopathy.

This review evaluated the current evidence on the relationship between sugar consumption and the development of retinal and eye conditions such as diabetic retinopathy, hypertensive retinopathy, age-related macular degeneration, non-arteritic anterior ischaemic optic neuropathy, and cataract. The authors note that sugar intake has risen five-fold over the past century, driven by sucrose and high-fructose corn syrup in processed foods and soft drinks. Furthermore, the review explores how refined carbohydrates and chronic hyperglycemia impact eye microvascular disease and retinal circulation.

Shows an association, not proof of cause and effect.

Kearney FM, Fagan XJ, Al-Qureshi S Clin Exp Ophthalmol, 2014. PMID 24373051

2014 / Review

Fasting triggers adaptive cellular responses and helps reduce obesity, hypertension, asthma, and rheumatoid arthritis in humans.

This review summarizes molecular mechanisms and clinical applications of fasting across organisms. In lower eukaryotes, chronic fasting extends longevity by reprogramming metabolic and stress resistance pathways, while intermittent or periodic fasting protects rodents against diabetes, cancers, heart disease, and neurodegeneration. In humans, fasting helps reduce obesity, hypertension, asthma, and rheumatoid arthritis. Fasting shows potential to delay aging and help prevent and treat disease while minimizing side effects associated with chronic dietary interventions.

Longo VD, Mattson MP Cell Metab, 2014. PMID 24440038

2014 / Narrative review

A review notes cocoa and dark chocolate may help reduce cardiovascular disease risk, though findings vary across populations and mechanisms remain debated.

This review discusses the associations of cocoa with decreased blood pressure and cardiovascular disease (CVD) risk reduction, alongside possible physiological mechanisms. Observations in the Kuna Indian population demonstrated cardiovascular health benefits from cocoa, though benefits have not been as robust in other groups. Cocoa components such as flavanols and theobromine may enhance endothelial function and improve hypertension, platelet aggregation and adhesion, insulin resistance, and hypercholesterolemia. However, no consensus has been reached on cocoa's precise physiologic role, and benefits may be influenced by production and processing stages.

Shows an association, not proof of cause and effect.

Latham LS, Hensen ZK, Minor DS J Clin Hypertens (Greenwich), 2014. PMID 24734311

2014 / Narrative review

Reducing salt intake lowers blood pressure, and population salt reduction programs offer potential for large health gains.

This review discusses the impact of dietary salt on high blood pressure and vascular disease. It notes that average population salt consumption is typically 5-10 times greater than physiological requirements. The authors state that reducing salt intake lowers blood pressure, blood pressure-lowering reduces vascular disease, and there is no evidence to suggest reducing salt intake will cause harm.

Neal B Can J Cardiol, 2014. PMID 24786439

2014 / Narrative commentary / review

A commentary reports an optimal sodium intake between 3 and 6 g/d, questioning the justification for population-wide sodium reduction.

This commentary examines policy positions and evidence regarding dietary sodium intake. It reports that evidence supports a strong association between sodium, blood pressure, and cardiovascular disease events in hypertensive individuals, the elderly, and those consuming > 6 g/d. However, it notes no association with clinical events at 3 to 6 g/d and a paradoxical higher rate of events at < 3 g/d, concluding that population-wide sodium reduction is not justified in countries such as Canada.

Shows an association, not proof of cause and effect.

Mente A, O'Donnell MJ, Yusuf S Can J Cardiol, 2014. PMID 24786440

2014 / Narrative review of prospective cohort studies

In Adventist cohorts, vegetarian and vegan diets were associated with lower risks of cardiovascular disease, diabetes, hypertension, and mortality.

This review evaluated evidence from three prospective cohorts of North American Adventists (Adventist Mortality Study, Adventist Health Study, and Adventist Health Study-2) comparing non-vegetarian to vegetarian patterns. Vegetarian diets conferred protection against cardiovascular diseases, cardiometabolic risk factors, some cancers, and total mortality. Compared with lacto-ovo-vegetarian diets, vegan diets appeared to offer additional protection against obesity, hypertension, type-2 diabetes, and cardiovascular mortality, with males experiencing greater health benefits than females. The authors note limited prospective data on vegetarian diets and body weight change.

Shows an association, not proof of cause and effect.

Le LT, Sabaté J Nutrients, 2014. PMID 24871675

2014 / Historical review

A strict rice-fruit diet was historically reported to reverse ECG changes and rapidly improve severe hypertension and related complications.

This paper reviews published historical clinical experiences starting in 1940 with a radical white rice and fruit diet for accelerated and ordinary hypertension. The treatment reported rapid reductions in blood pressure, improvements in renal failure, papilledema, and congestive heart failure, along with normalization of hypertensive ECG changes. Patients who adhered and were transitioned to a low-fat, largely vegetarian diet over months reportedly maintained a normal, active life without medications.

Estes EH, Kerivan L J Electrocardiol, 2014. PMID 24996514

2014 / Phytochemical and pharmacological review

Hibiscus sabdariffa extracts show antioxidant, anti-hypertensive, and metabolic effects, but well-designed trials with characterized preparations are needed.

This review evaluates the phytochemical and pharmacological evidence for Hibiscus sabdariffa L. (Hs, roselle). In vitro and in vivo studies, along with some clinical trials, show antibacterial, antioxidant, nephro- and hepato-protective, diuretic, lipid-lowering, anti-diabetic, and anti-hypertensive effects. Proposed mechanisms include antioxidant actions, enzyme inhibition (α-glucosidase, α-amylase, ACE), and vaso-relaxant effects, likely driven by phenolic acids, organic acids, and anthocyanins. The authors note an excellent safety and tolerability record, but emphasize that most evidence is based on poorly characterized extracts and more well-designed controlled clinical trials using characterized preparations are needed.

Da-Costa-Rocha I, Bonnlaender B, Sievers H, et al. Food Chem, 2014. PMID 25038696

2014 / Narrative review

Moderate reduction of dietary salt intake is generally effective for lowering blood pressure and improving cardiovascular health.

Over the past century, research has examined salt intake in relation to blood pressure and cardiovascular mortality. Moderate reduction of dietary salt intake is generally an effective measure to lower blood pressure. Reducing intake from 9-12 g/day to recommended levels below 5-6 g/day is noted to have major beneficial effects on cardiovascular health and healthcare costs. The review notes that while some scientists suggest potential risks at extremes of low salt intake, salt reduction remains a recommended public health priority.

Ha SK Electrolyte Blood Press, 2014. PMID 25061468

2014 / Narrative review

A narrative review highlights evidence and mechanisms for flaxseed and its extracts in managing blood pressure.

This review examines recent data regarding flaxseed and its extracts for blood pressure regulation from both animal models and clinical trials. It notes that a recent year-long randomized controlled trial found impressive reductions in blood pressure among patients with hypertension consuming flaxseed daily. Proposed anti-hypertensive mechanisms and the potential of flaxseed as a global anti-hypertensive therapy are discussed.

Caligiuri SP, Edel AL, Aliani M, et al. Curr Hypertens Rep, 2014. PMID 25342643

2014 / Narrative review

Inorganic nitrate supplementation may enhance exercise performance and provide cardiovascular benefits such as reduced blood pressure.

This review summarizes scientific evidence regarding inorganic nitrate supplementation, including beetroot juice and sodium nitrate, for human health and physical performance. Multiple studies support nitrate supplementation as an effective way to improve exercise performance, alongside modest cardiovascular benefits such as lowering blood pressure, improving blood flow, and increasing oxygen driving pressure in microcirculation. These effects have been observed after both single-bolus and daily supplementation. The authors note that further research is needed to examine anaerobic performance, interactions with other vegetable compounds, specific dose-response relationships, supplementation periods extending beyond 15 days, and chronic safety.

Clements WT, Lee SR, Bloomer RJ Nutrients, 2014. PMID 25412154

2013 / Narrative review

Dietary nitrate demonstrates beneficial vascular effects such as lowering blood pressure and improving endothelial function via the nitrate-nitrite-NO pathway.

This review discusses the vascular effects of dietary nitrate from vegetables such as green leafy vegetables and beetroot through the nitrate-nitrite-nitric oxide pathway. Dietary nitrate has been shown to reduce blood pressure, inhibit platelet aggregation, preserve or improve endothelial dysfunction, and enhance exercise performance in healthy individuals and patients with peripheral arterial disease. Epidemiological studies suggest reduced cardiovascular risk with nitrate-rich vegetable diets, though associations with cancer remain unproven. A major limitation is the lack of data concerning the long-term effects of dietary nitrate.

Lidder S, Webb AJ Br J Clin Pharmacol, 2013. PMID 22882425

2013 / Narrative review

A review notes wide-ranging reported health benefits of vitamin D but cautions that high-dose supplementation may pose risks to phosphate regulation.

This review examines the extensive research surrounding vitamin D status and health outcomes. While adequate vitamin D status has been linked to reduced risks of multiple cancers, infections, cardiovascular diseases, diabetes, and other conditions, the author suggests enthusiasm may be excessively optimistic. The review highlights that serum 25-OHD(3) can be poorly responsive to intake, local tissue intoxication may occur at lower serum levels than recognized, and prolonged consumption of thousands of international units of vitamin D may interfere with phosphate homeostasis regulated by FGF23 and Klotho.

Glade MJ Nutrition, 2013. PMID 23085014

2013 / Narrative review

A review highlights evidence linking conventional and novel vascular risk factors to vascular cognitive impairment.

This review describes current nomenclature for vascular cognitive impairment (VCI) from histopathological and clinical perspectives, emphasizing prevention and risk factor modification. Substantial evidence from observational studies and clinical trials indicates that conventional risk factors—such as hypertension, diabetes, dyslipidemia, smoking, and atrial fibrillation—play a role in VCI development, while novel factors like metabolic syndrome are also associated with cognitive dysfunction. The authors state targeting these risk factors will minimize VCI burden in aging populations, but emphasize that future research is needed to clarify the role of risk factor modification in limiting vascular brain injury to prevent VCI and progression to dementia.

Rincon F, Wright CB Curr Opin Neurol, 2013. PMID 23254555

2013 / Comprehensive narrative review of animal and human studies

Hibiscus sabdariffa tea or extracts significantly lowered blood pressure and improved lipid profiles in randomized clinical trials.

This review evaluated animal and human studies on Hibiscus sabdariffa (HS) for treating hypertension and hyperlipidemia. In randomized controlled trials, daily consumption of HS tea or extract significantly lowered systolic and diastolic blood pressure in adults with pre to moderate hypertension and type 2 diabetes, performing as well as Captopril but less effectively than Lisinopril. Furthermore, over half of the RCTs indicated daily HS intake favorably influenced lipid profiles by reducing total cholesterol, LDL-C, and triglycerides, and increasing HDL-C. The authors conclude that while HS is promising, more high-quality animal and human studies are required.

Hopkins AL, Lamm MG, Funk JL, et al. Fitoterapia, 2013. PMID 23333908

2013 / Narrative review of epidemiological and clinical studies

Evidence linking fish intake and dietary n-3 PUFAs to type 2 diabetes risk remains controversial.

This review examines epidemiological and clinical studies evaluating the role of dietary n-3 polyunsaturated fatty acids (PUFAs) in type 2 diabetes mellitus (T2DM). Dietary n-3 PUFAs have been associated with anti-inflammatory effects, improved endothelial function, blood pressure control, and reductions in hypertriglyceridemia and insulin insensitivity. While some epidemiological studies report a lower prevalence of T2DM in populations consuming large amounts of seafood, current evidence regarding fish intake, dietary n-3 PUFAs, and T2DM risk is controversial.

Shows an association, not proof of cause and effect.

Jafari T, Fallah AA, Azadbakht L Maturitas, 2013. PMID 23384976

2013 / Narrative review

Emerging data indicate kiwifruit is beneficial for cardiovascular disease prevention, alongside general fruit and vegetable benefits.

This review discusses the cardioprotective properties of fruits, vegetables, and kiwifruit. Emerging data indicate that kiwifruit is beneficial in cardiovascular disease prevention, noting that consumption of two or three fruit per day for 28 days or more lowers platelet hyperactivity, plasma lipids, and blood pressure in human volunteers. The authors suggest kiwifruit may provide a dietary means to favorably modify cardiovascular risk factors.

Duttaroy AK Adv Food Nutr Res, 2013. PMID 23394993

2013 / Narrative review

Legumes contain dietary fibers, proteins, and phytochemicals that may contribute to cardiometabolic risk prevention.

This review provides an overview of the nutritional quality of legumes and their potential role in cardiometabolic risk prevention. Per capita daily legume consumption ranges between 8 and 23 g in Mediterranean European countries, compared to less than 5 g in Northern Europe. Legumes contain bioactive phytochemicals—including enzyme inhibitors, lectins, phytoestrogens, oligosaccharides, saponins, and phenolic compounds—that may protect against coronary heart disease, diabetes, high blood pressure, and inflammation. The authors note that the synergistic or antagonistic effects, interactions with other diet components, and precise mechanisms of action of these phytochemical mixtures remain challenging to fully understand.

Bouchenak M, Lamri-Senhadji M J Med Food, 2013. PMID 23398387

2013 / Narrative review

A review examined evidence on chocolate and cocoa consumption, noting research on antioxidant potential alongside contradictory results.

This review evaluates research from the last decade examining the health benefits and risks of chocolate consumption. Although historically associated with conditions such as acne, obesity, and cardiovascular disease, cocoa is now researched for phenolic compounds related to ageing, oxidative stress, blood pressure regulation, and atherosclerosis. The review notes that contradictory study results and methodological concerns complicate the understanding of chocolate's overall health effects.

Latif R Neth J Med, 2013. PMID 23462053

2013 / Narrative review with a case study

Plant-based diets are low-risk interventions that may lower BMI, blood pressure, HbA1C, cholesterol, and ischemic heart disease mortality.

This article provides an update for physicians on plant-based diets, defined as regimens encouraging whole, plant-based foods while discouraging meats, dairy, eggs, and refined foods, accompanied by a case study. Research indicates these diets are cost-effective interventions that may lower body mass index, blood pressure, HbA1C, cholesterol levels, medication needs, and ischemic heart disease mortality. The authors suggest physicians consider recommending plant-based diets to patients, particularly those with obesity, diabetes, cardiovascular disease, or hypertension.

Tuso PJ, Ismail MH, Ha BP, et al. Perm J, 2013. PMID 23704846

2013 / Narrative review

Kiwifruit consumption may offer multiple health benefits including improved lipids, blood pressure, iron status, and digestive function.

This review evaluates the health benefits and nutrient density of green and gold kiwifruit cultivars. Kiwifruit as part of a healthy diet may increase HDL cholesterol, decrease triglycerides, platelet aggregation, and elevated blood pressure, while green kiwifruit aids digestion and laxation. Consuming gold kiwifruit with iron-rich meals improves poor iron status, and kiwifruit intake may support immune function and reduce cold or flu-like illness incidence and severity in children and older adults. However, kiwifruit is allergenic, with reported reactions ranging from mild symptoms to severe events.

Stonehouse W, Gammon CS, Beck KL, et al. Can J Physiol Pharmacol, 2013. PMID 23746068